The Claim
In adults with type 2 diabetes, once-weekly exenatide does not significantly alter estimated glomerular filtration rate (eGFR) over the study period, with a least squares mean difference of 0.21 mL/min/1.73 m² (95% CI: −0.27 to 0.70), indicating no clinically meaningful effect on kidney function as assessed by eGFR.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Taking a weekly exenatide shot doesn’t really change how well your kidneys are working if you have type 2 diabetes — the numbers stayed about the same over time.
See the scientific wording
Once-weekly exenatide does not significantly alter estimated glomerular filtration rate (eGFR) in adults with type 2 diabetes over the study period, with a least squares mean difference of 0.21 mL/min/1.73 m² (95% CI −0.27 to 0.70), indicating no clinically meaningful effect on kidney function as measured by eGFR.
What the research says
1 studyThe study looked at how once-weekly exenatide affects kidney function and found it doesn’t make a real difference in eGFR, just like the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.